An overview of how nanomaterials regulate stem cell biological functions and activate associated signaling pathways is provided, followed by a discussion of future directions and challenges in this field.
Abstract
Stem cells possess self-renewal capacity and differentiation potential. Under appropriate conditions, they can continuously divide to generate more stem cells of the same type or differentiate into various specialized cell types, thereby contributing to the formation of diverse tissues and organs. In tissue engineering and regenerative medicine, stem cells serve as key elements for repairing or replacing functional tissues lost due to disease, injury, or aging. The development of nanomaterials has provided new tools and approaches for stem cell research, particularly in the biomedical field, where they are widely applied in drug delivery, biosensing, medical imaging, and tissue engineering. Moreover, through interactions with cell membranes and/or intracellular components, nanomaterials can modulate key stem cell functions — including differentiation, proliferation, and adhesion — thereby enhancing the therapeutic efficacy of stem cells in biomedical applications. This review first introduces the main characteristics and potential risks associated with the application of nanomaterials to stem cells. The subsequent section provides an overview of how nanomaterials regulate stem cell biological functions and activate associated signaling pathways, followed by a discussion of future directions and challenges in this field.
This review critically analyzes the immunoregulatory pathways involved in inflammatory and immune-related disorders, and directly links these mechanisms to the challenges within the tumor microenvironment.
The studies on MSC fusion reviewed here suggest the potential of the resulting hybrids for tissue regeneration, particularly in the cardiovascular, muscular, and nervous systems, however, there is also evidence that spontaneous MSC fusion is a rare event.
T. Burnik, Metka Pirnat, Matjaž Jeras et al.· Cellular & Molecular Bio...· 0 citations
Although further study is needed to support the clinical application of i-dMSCs, these results indicate that they have the potential to become the seed cell for stem cell therapy, providing new ideas for the field of regenerative medicine.
This review systematically examines the biogenesis of MSC-EVs, focusing specifically on exosomes, microvesicles, and apoptotic vesicles, and introduces an emerging approach utilizing engineered MSC aggregate-derived EVs inspired by organ morphogenesis.
Shi‐Han Mu, Rang Li, Peng‐fei Wang et al.· Burns & Trauma· 1 citation
The engineering of nano‐microscale materials with precisely tailored chemo‐mechanical cues has the potential to revolutionize stem cell therapy, enhancing their capacity for self‐renewal and lineage specification and unlocking its full potential for healthcare applications.
Rajendra K. Singh, Varsha Sagar, Dr. Amal George Kurian et al.· BMEMat· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.